A 2-year moratorium on direct-to-consumer advertising for some newly approved drugs is part of a bipartisan bill introduced in the Senate intended to increase prescription medication safety. The bill (S 3807; http://thomas.loc.gov) also calls on pharmaceutical manufacturers to conduct better safety planning before a drug receives approval from the Food and Drug Administration. The government agency would also have to improve its postmarketing surveillance.
Mitka M. Drug Ad Moratorium? JAMA. 2006;296(10):1225. doi:10.1001/jama.296.10.1225-a
Coronavirus Resource Center
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: